NCT05981911 Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
| NCT ID | NCT05981911 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seung-Jung Park |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-12-14 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-12-14 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility Criteria
Inclusion Criteria: 1. Patients ≥ 19 years old 2. Patients receiving Xience-Skypoint™ stents. 3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: 1. Patients with a mixture of other DESs 2. Terminal illness with life expectancy \<1 year 3. Patients with cardiogenic shock
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05981911 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05981911 currently recruiting?
Yes, NCT05981911 is actively recruiting participants. Contact the research team at cvcrc5@amc.seoul.kr for enrollment information.
Where is the NCT05981911 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05981911 clinical trial?
NCT05981911 is sponsored by Seung-Jung Park. The trial plans to enroll 2,000 participants.